Atlas Trials

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

Clinical trial NCT03251300 · UNKNOWN

Trial details

NCT number
NCT03251300
Sponsor
Far Eastern Memorial Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive Bladder Syndrome
Start date
2017-08-01
Primary completion
2024-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.